hrcak mascot   Srce   HID

Stručni rad
https://doi.org/10.15644/asc48/3/7

Topikalni steroidi i CO2-laser u terapiji refraktorne lihenoidne reakcije na lijekove i lihenoidne kontaktne lezije: prikaz slučaja

Kobkan Thongprasom   ORCID icon orcid.org/0000-0001-7627-919X ; Odjel za oralnu medicinu Stomatološkog fakulteta Sveučilišta Chulalongkorn, Bangkok, Tajland
Somchai Sessririsombat ; Odjel za oralnu maksilofacijalnu kirurgiju Stomatološkog fakulteta Sveučilišta Chulalongkorn, Bangkok, Tajland
Kanjana Singkharotai ; Odjel za oralnu maksilofacijalnu kirurgiju Stomatološkog fakulteta Sveučilišta Chulalongkorn, Bangkok, Tajland
Achara Vathanasanti ; Odjel za farmakologiju Stomatološkog fakulteta Sveučilišta Chulalongkorn, Bangkok, Tajland
Keskanya Subbalek ; Odjel za oralnu maksilofacijalnu kirurgiju Stomatološkog fakulteta Sveučilišta Chulalongkorn, Bangkok, Tajland

Puni tekst: hrvatski, pdf (374 KB) str. 224-229 preuzimanja: 185* citiraj
APA 6th Edition
Thongprasom, K., Sessririsombat, S., Singkharotai, K., Vathanasanti, A. i Subbalek, K. (2014). Topikalni steroidi i CO2-laser u terapiji refraktorne lihenoidne reakcije na lijekove i lihenoidne kontaktne lezije: prikaz slučaja. Acta stomatologica Croatica, 48 (3), 224-229. https://doi.org/10.15644/asc48/3/7
MLA 8th Edition
Thongprasom, Kobkan, et al. "Topikalni steroidi i CO2-laser u terapiji refraktorne lihenoidne reakcije na lijekove i lihenoidne kontaktne lezije: prikaz slučaja." Acta stomatologica Croatica, vol. 48, br. 3, 2014, str. 224-229. https://doi.org/10.15644/asc48/3/7. Citirano 29.09.2020.
Chicago 17th Edition
Thongprasom, Kobkan, Somchai Sessririsombat, Kanjana Singkharotai, Achara Vathanasanti i Keskanya Subbalek. "Topikalni steroidi i CO2-laser u terapiji refraktorne lihenoidne reakcije na lijekove i lihenoidne kontaktne lezije: prikaz slučaja." Acta stomatologica Croatica 48, br. 3 (2014): 224-229. https://doi.org/10.15644/asc48/3/7
Harvard
Thongprasom, K., et al. (2014). 'Topikalni steroidi i CO2-laser u terapiji refraktorne lihenoidne reakcije na lijekove i lihenoidne kontaktne lezije: prikaz slučaja', Acta stomatologica Croatica, 48(3), str. 224-229. https://doi.org/10.15644/asc48/3/7
Vancouver
Thongprasom K, Sessririsombat S, Singkharotai K, Vathanasanti A, Subbalek K. Topikalni steroidi i CO2-laser u terapiji refraktorne lihenoidne reakcije na lijekove i lihenoidne kontaktne lezije: prikaz slučaja. Acta stomatologica Croatica [Internet]. 2014 [pristupljeno 29.09.2020.];48(3):224-229. https://doi.org/10.15644/asc48/3/7
IEEE
K. Thongprasom, S. Sessririsombat, K. Singkharotai, A. Vathanasanti i K. Subbalek, "Topikalni steroidi i CO2-laser u terapiji refraktorne lihenoidne reakcije na lijekove i lihenoidne kontaktne lezije: prikaz slučaja", Acta stomatologica Croatica, vol.48, br. 3, str. 224-229, 2014. [Online]. https://doi.org/10.15644/asc48/3/7
Puni tekst: engleski, pdf (374 KB) str. 224-229 preuzimanja: 325* citiraj
APA 6th Edition
Thongprasom, K., Sessririsombat, S., Singkharotai, K., Vathanasanti, A. i Subbalek, K. (2014). Topical Steroids and CO2 Laser in the Treatment of Refractory Oral Lichenoid Drug Reaction and Lichenoid Contact Lesion: a Case Report. Acta stomatologica Croatica, 48 (3), 224-229. https://doi.org/10.15644/asc48/3/7
MLA 8th Edition
Thongprasom, Kobkan, et al. "Topical Steroids and CO2 Laser in the Treatment of Refractory Oral Lichenoid Drug Reaction and Lichenoid Contact Lesion: a Case Report." Acta stomatologica Croatica, vol. 48, br. 3, 2014, str. 224-229. https://doi.org/10.15644/asc48/3/7. Citirano 29.09.2020.
Chicago 17th Edition
Thongprasom, Kobkan, Somchai Sessririsombat, Kanjana Singkharotai, Achara Vathanasanti i Keskanya Subbalek. "Topical Steroids and CO2 Laser in the Treatment of Refractory Oral Lichenoid Drug Reaction and Lichenoid Contact Lesion: a Case Report." Acta stomatologica Croatica 48, br. 3 (2014): 224-229. https://doi.org/10.15644/asc48/3/7
Harvard
Thongprasom, K., et al. (2014). 'Topical Steroids and CO2 Laser in the Treatment of Refractory Oral Lichenoid Drug Reaction and Lichenoid Contact Lesion: a Case Report', Acta stomatologica Croatica, 48(3), str. 224-229. https://doi.org/10.15644/asc48/3/7
Vancouver
Thongprasom K, Sessririsombat S, Singkharotai K, Vathanasanti A, Subbalek K. Topical Steroids and CO2 Laser in the Treatment of Refractory Oral Lichenoid Drug Reaction and Lichenoid Contact Lesion: a Case Report. Acta stomatologica Croatica [Internet]. 2014 [pristupljeno 29.09.2020.];48(3):224-229. https://doi.org/10.15644/asc48/3/7
IEEE
K. Thongprasom, S. Sessririsombat, K. Singkharotai, A. Vathanasanti i K. Subbalek, "Topical Steroids and CO2 Laser in the Treatment of Refractory Oral Lichenoid Drug Reaction and Lichenoid Contact Lesion: a Case Report", Acta stomatologica Croatica, vol.48, br. 3, str. 224-229, 2014. [Online]. https://doi.org/10.15644/asc48/3/7

Rad u XML formatu

Sažetak
Pacijentica u dobi od 54 godine bila je primljena s jakim bolovima u gingivi i obraznim sluznicama. Oralnim pregledom uočene su plamenocrvene desni i ulcerirane lezije s bijelim strijama prekrivene pseudomembranama na objema obraznim sluznicama. Bolovala je od hipertenzije, dislipidemije, subkliničkog hipotiroidizma i artritisa. Bila je pod terapijom atorvastatina, hidroklorotijazida, valsartana, levotiroksina i nesteroidnih protuupalnih lijekova (NSAID). Oralne lezije pacijentice blago su se smanjile nakon terapije kremom s pimekrolimusom, 0,1-postotnim triamkinolon-acetonidom u orabazi i injekcijama. Nakon što je Diclofenac zamijenjen Tenoxicamom i oralne lezije tretirane različitim steroidima, stanje se znatno poboljšalo. Na temelju biopsije bukalne sluznice dijagnosticiran je lihen planus. Patch-test pokazao je pozitivnu reakciju na živu, zlatni natrijev tiosulfat i platinu. Nakon godinu dana na lijevoj obraznoj sluznici pojavila se crvena, okrugla papilomatozna lezija. Patohistološkim nalazom potvrđeno je da je riječ o nespecifičnom
ulkusu s kroničnom upalom. Lezije su buknule nakon zamjene amalgamskih ispuna u zubima krunama. Nakon terapije ugljično-dioksidnim laserom, lezije su se donekle smanjile. Direktna i indirektna imunofluorescencija lezija bila je negativna. Ovaj prvi prikaz slučaja pokazuje da tijekom palijativne terapije refraktorne oralne lihenoidne lezije snažnim topikalnim steroidima sedam godina
nije bilo nuspojava. U ovom slučaju CO2-laser može biti alternativna terapija.

Ključne riječi
Lihen planus, oralni; Patch testovi; laseri, plinski; steroidi; klobetasol; fluokinolon acetonid

Hrčak ID: 127328

URI
https://hrcak.srce.hr/127328

▼ Article Information



Introduction

Oral lichenoid drug reactions (OLDR) characterized by white striae and erythematous or ulcerative area that erupts after administration of drugs such as angiotensin-converting enzyme (ACE) inhibitors, non-steroidal anti-inflammatory drugs (NSAIDs), hypoglycemic drugs, penicillamine, etc. (1). The oral lesion of OLDR is similar to OLP both clinically and histopathologically (2). Difficulties in distinguishing between these two diseases resulted in difficulties in treatment and management of the lesions. However, the diagnosis of OLDR is rendered when oral lesions erupt after administration of the drugs and the lesions can be resolved after withdrawal of suspected drugs. Oral lichenoid contact lesions (OLCL) are in direct contact with offending agents such as amalgam or metal restorative materials. When the amalgam restoration or metal restorative materials are removed, the lesions are gradually resolved. However, replacement of restorative materials in OLCL is still controversial (3). Moreover, not all cases can be treated successfully, particularly in cases with multiple drugs administration or OLDR being concurrent with OLCL. This presented case was one of both OLDR and OLCL that was a challenge to manage. Various topical steroids still remain the first line of therapy to reduce pain and inflammation in this case as well as medical consultation. There is no specific treatment in refractory cases of OLDR and OCCL. However, the withdrawal of a suspected drug is useful during the treatment of refractory cases and can enhance healing of the lesions (4). A long-term follow-up is needed to improve the quality of life of the patient and to detect early lesions, should malignant transformation occur. To our knowledge, this was the first case report that showed the palliative treatment of refractory oral lesions with potent topical steroids for 7 years without side-effects.

A case report

A 54-year-old female was referred to the Oral Medicine clinic at the Faculty of Dentistry, Chulalongkorn University, Bangkok, Thailand in 2006 with a chief complaint of pain on the gingiva, the right and the left buccal mucosa for 5 years. She experienced pain when eating hot and spicy food. The otorhinolaryngologist treated her with pimecrolimus (Elidel) cream 1%, sore mouth gel, triamcinolone acetonide 0.1% orabase and Kamistad gel. Kamistad gel is an oral therapeutic gel with ingredients of Chamomile flower extract and Lidocaine HCl which is indicated for the treatment of painful and inflammatory processes of the oral mucous membrane was also treated, but the oral lesions showed only slight improvement. Triamcinolone acetonide injection (Kenacort) 10 mg/ml was also injected into the lesion 4 times, but no improvement. Her physician referred this patient with the histopathological report of oral lichen planus with no malignancy change from the biopsy specimen from the buccal mucosa. The skin biopsy from her leg was also done by her physician and it was pigmented purpuric dermatitis (PPD). All patch tests were negative at first. Surprisingly, 4 years later, the patch test showed positivity to mercury and palladium. Anti-HBs was positive with 138 mIU/mL, whereas anti-HCV was negative. Investigations of serology for autoimmune disease showed all negative for LE cells, antinuclear factor and anti DNA.

Regarding systemic diseases, she had a history of hypertension, dyslipidemia, subclinical hypothyroidism and arthritis. Her medications were Atorvastatin calcium ½ tab OD, Hydrochlorothiazide 50 mg, ¼ tab OD, Valsartan ½ OD, Eltroxin (levothyroxine) 0.1mg, 1 tab OD, Difflam lozenge 3 mg 1 tab tid pc and Diclofenac potassium 1 tab OD.

Oral findings in this case at the first visit to the Oral Medicine clinic, Faculty of Dentistry, Chulalongkorn University revealed ulcerative, erythematous lesions with white striae covered with pseudomembranes on the right and the left buccal mucosa (Figure 1 a, b). Her gingiva showed generalized fiery red on marginal and attached gingiva. Scraping from the surface of the lesions and using potassium hydroxide 10% was positive for both hyphal and yeast forms of Candida. The diagnosis at the initial visit was oral lichenoid drug reaction (OLDR) with candidiasis. Because the oral lichen planus-like lesions erupted after using medications mentioned above the diagnosis of OLDR was established. We suggested to her physician to change the medications and treated her oral lesions with fluocinolone with clotrimazole gel 0.1%, sodium bicarbonate mouthwash and folic acid 5 mg, 1 tab bid. After that, her physician changed diclofenac to tenoxicam one month later. However, her symptoms remained the same so the fluocinolone acetonide 0.1% in solution was used instead fluocinolone with clotrimazole gel 0.1%. Two months later, her symptoms showed approximately 50% improvement, but the right and left buccal mucosa to retromolar areas showed ulcers covered by yellowish pseudomembrane and surrounded with white striae. Dexamethasone mouthwash 0.05% was used for the treatment. Antihypertensive drug (Hydrochlorothiazide) was recommended to be replaced by others. After the replacement, hydrochlorothiazide with valsartan for 4 months, the lesions showed improvement. The potent topical steroids such as clobetasol propionate 0.05%, fluocinolone acetonide 0.1% orabase were used to treat the oral lesions.

Figure 1 a, b First visit, ulcerative and erythematous lesions with white striae covered with pseudomembranes on the right and the left buccal mucosa
ASC_48(3)_224-229-f1__a__b

In August 2007, her gingival and the right buccal mucosa showed marked improvement, but the left buccal mucosa showed round papillomatous-like lesions, size 0.5x0.5 cm. and 0.3x0.3 cm. with red color (Figure 2 a, b). Biopsy specimen was taken from this area and the histopathological report was non-specific ulcer with chronic inflammation. The sections revealed soft tissue with denuded epithelium showing fibrinous exudate coverage. Large amounts of superficial polymorphonuclear leukocyte infiltration were seen. A number of new forming blood vessels, plasma cells as well as lymphocytes were seen in the area (Figure 3).

Figure 2 a, b The right buccal mucosa showed improvement. The left buccal mucosa showed round papillomatous-like lesions, size 0.5x0.5 cm. and 0.3x0.3 cm. with red color
ASC_48(3)_224-229-f2__a__b
Figure 3 The sections reveal soft tissue with denuded epithelium showing fibrinous exudate coverage. Large amount of superficial polymorphonuclear leukocyte infiltration is seen. Numbers of new forming blood vessels, plasma cells as well as lymphocytes are seen at the area.
ASC_48(3)_224-229-f3

In May 2009, the patient was treated with valsartan, levothyroxine sodium, and simvastatin. Her dentist replaced the amalgam restoration on the left mandibular second molar with a full porcelain crown. Generalized fiery red gingiva, the right and left buccal mucosa flared up with pseudomembrane covering the surface of the lesions (Figure 4 a, b, c). Triamcinolone acetonide 0.1%, mouthwash, clobetasol propionate 0.05% orabase, dexamethasone 0.05% mouthwash were used to treat the lesions. The patient was referred to the Oral and Maxillofacial Surgery department for CO2 laser. After the treatment with CO2 laser 5 watt for 2 minutes twice, the oral lesions showed improvement (Figure 5 a, b, c).

Figure 4 a, b, c All gingiva, the right and the left buccal mucosa flared up particularly pseudomembrane covered on the surface of the lesions. Her gingiva was generalized fiery red with inflammation
ASC_48(3)_224-229-f4__a__b__c
Figure 5 After the CO2 laser treatment, the lesions showed improvement
ASC_48(3)_224-229-f5

In November, 2013, the left mandibular second molar was extracted by her dentist but the lesions still persisted and flared up. Direct and indirect immunofluorescence tests were assessed to exclude the lesions from oral pemphigus or mucous membrane pemphigoid because the oral lesions on the gingiva and buccal mucosa were similar to those lesions. The specimen was taken from the right buccal mucosa and indirect immunofluorescence report was negative to circulating IgG anti-basement membrane zone antibody. Direct immunofluorescence study showed negative findings to IgG, IgA, IgM, C3 and fibrin.

Discussion

Patients with many systemic diseases and taking multiple medications can have severe OLDR.

Hydrochlorothiazide, levothyroxine, NSAIDs can induce severe and chronic OLDR (1). The diagnosis criterion for OLDR is the eruption of oral lesions after taking suspected medications. The patient described here had been taking multiple medications including hydrochlorothiazide, levothyroxine and NSAIDs which have been reported for inducing severe and chronic OLDR (1).

The diagnosis of OLCL was made when the lesion appeared after direct contact to dental restoration such as amalgam or metal crown. With the removal and replacement of the suspected causative material, the majority of such OLCLs resolved within several months (1). The anatomy of the buccal mucosa with no mucobuccal fold might affect the successful treatment in this case. The direct absorption of topical steroid when the buccal mucosa is close to the teeth might not occur properly. Topical steroids application in long-term treatment of oral lichenoid lesions should be considered. However, continued use of potent topical steroids has been found to be useful in the management of severe oral lesions in these patients with many systemic diseases. No serious side-effects from treatment with topical steroids for oral lichenoid lesions in this case. Moreover, carbon dioxide laser can be used as an alternative treatment in this refractory case. However, maintaining good oral hygiene should be considered during follow-up.

Ethical considerations for dentists during management of recalcitrant oral lesions should be taken into account. The lesion may resolve if amalgam filling is replaced by composite resin (5). The procedure of crown preparation for full porcelain might be affecting the surrounding tissues and could trigger the lesions. However, replacing amalgam fillings or changing a metal crown is not always successful but the dentists should consider it during management of such patients with OLCL. Therefore, patients should be informed of the possibilities of positive or negative outcomes before replacement of the restoration or the crown. Positivity to patch testing was an inconsistent and generally weak predictor of improvement following amalgam removal (6). The cooperation of oral medicine specialists, other specialties and physicians is important during management of severe oral lesions. A long-term follow-up is needed to improve the quality-of-life in the patient with refractory oral lesions.

Conclusion

OLDR and OLCL have been known for a very long time in oral medicine and a complete cure of the lesions is very difficult to achieve. Treatment modalities such as potent topical steroids and drug replacement are standard of care in OLDR cases. We presented a refractory case with OLDR and OLCL who was indeed a challenging one to treat and manage. Continuous treatment of refractory oral lesions with potent topical steroids and CO2 laser showed no serious side-effects during the long-term follow-up. This was the first case report that showed the palliative treatment of oral lesions with potent topical steroids for 7 years without side-effects. Therefore, the treatment modalities in this case report could improve the quality-of-life in patients with many systemic diseases.

Acknowledgements

We would like to thank Assoc. Prof. Somsri Rojwattanasirivej and Dr. Ekarat Pattrataratip, Oral Pathology Department for the histopathology report. We also thank Assoc. Prof. Kittipong Dhanuthai for editing this manuscript. This case was presented during the table discussion of the World Workshop in Oral Medicine VI, Orlando, USA 12 April, 2014.

References

1 

Seymour RA, Rudralingham M. Oral and dental adverse drug reactions. Periodontol 2000. 2008;46:9–26. DOI: http://dx.doi.org/10.1111/j.1600-0757.2008.00226.x PubMed: http://www.ncbi.nlm.nih.gov/pubmed/18201343

2 

Al-Hashimi I, Schifter M, Lockhart PB, Wray D, Brennan M, Migliorati CA, et al. Oral lichen planus and oral lichenoid lesions: diagnostic and therapeutic considerations. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007 Mar;103 Suppl:25.e1–12. DOI: http://dx.doi.org/10.1016/j.tripleo.2006.11.001 PubMed: http://www.ncbi.nlm.nih.gov/pubmed/17261375

3 

Baccaglini L, Thongprasom K, Carrozzo M, Bigby M. Urban legends series: lichen planus. Oral Dis. 2013 Mar;19(2):128–43. DOI: http://dx.doi.org/10.1111/j.1601-0825.2012.01953.x PubMed: http://www.ncbi.nlm.nih.gov/pubmed/22788669

4 

Bagan VJ, Thongprasom K, Scully C. Adverse oral reactions associated with the COX-2 inhibitor Rofecoxib. Oral Dis. 2004 Nov;10(6):401–3. DOI: http://dx.doi.org/10.1111/j.1601-0825.2004.01024.x PubMed: http://www.ncbi.nlm.nih.gov/pubmed/15533219

5 

Laeijendecker R, Dekker SK, Burger PM, Mulder PG, Van Joost T, Neumann MH. Oral lichen planus and allergy to dental amalgam restorations. Arch Dermatol. 2004 Dec;140(12):1434–8. DOI: http://dx.doi.org/10.1001/archderm.140.12.1434 PubMed: http://www.ncbi.nlm.nih.gov/pubmed/15611418

6 

Laine J, Happonen RP, Vainio O, Kalimo K. In vitro lymphocyte proliferation test in the diagnosis of oral mucosal hypersensitivity reactions to dental amalgam. J Oral Pathol Med. 1997 Sep;26(8):362–6. DOI: http://dx.doi.org/10.1111/j.1600-0714.1997.tb00231.x PubMed: http://www.ncbi.nlm.nih.gov/pubmed/9379425


This display is generated from NISO JATS XML with jats-html.xsl. The XSLT engine is libxslt.

[engleski]

Posjeta: 845 *